R-ESHAP Followed by Autologous Transplantation for Refractory or Relapsed Diffused Large B-cell Lymphoma
Status:
Unknown status
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The aim of study is to prove R-ESHAP regimen followed by autologous stem cell transplantation
as salvage treatment in patients with refractory or relapsed diffuse large B-cell lymphoma is
effective.